Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin
Abstract
Follistatin (FS) inhibits several members of the TGF-beta superfamily, including myostatin (Mstn), a negative regulator of muscle growth. Mstn inhibition by FS represents a potential therapeutic approach of muscle atrophy. The aim of our study was to investigate the mechanisms of the FS-induced muscle hypertrophy. To test the role of satellite cells in the FS effect, we used irradiation to destroy their proliferative capacity. FS overexpression increased the muscle weight by about 37% in control animals, but the increase reached only 20% in irradiated muscle, supporting the role of cell proliferation in the FS-induced hypertrophy. Surprisingly, the muscle hypertrophy caused by FS reached the same magnitude in Mstn-KO as in WT mice, suggesting that Mstn might not be the only ligand of FS involved in the regulation of muscle mass. To assess the role of activin (Act), another FS ligand, in the FS-induced hypertrophy, we electroporated FSI-I, a FS mutant that does not bind Act with high affinity. Whereas FS electroporation increased muscle weight by 32%, the muscle weight gain induced by FSI-I reached only 14%. Furthermore, in Mstn-KO mice, FSI-I overexpression failed to induce hypertrophy, in contrast to FS. Therefore, these results suggest that Act inhibition may contribute to FS-induced hypertrophy. Finally, the role of Act as a regulator of muscle mass was supported by the observation that ActA overexpression induced muscle weight loss (-15%). In conclusion, our results show that satellite cell proliferation and both Mstn and Act inhibition are involved in the FS-induced muscle hypertrophy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Follistatin might enhance SkM hypertrophy due to its ability to bind and neutralize myostatin, increasing the mass of SkM available for glucose and FFA uptake and oxidation.
“Follistatin might enhance SkM hypertrophy due to its ability to bind and neutralize myostatin [184,199], increasing the mass of SkM available for glucose and FFA uptake and oxidation.”
Follistatin binds and inactivates myostatin, further inhibiting its proinflammatory effects.
“FGF21 was determined to increase glucocorticoid action [164] and the secretion of adiponectin [165], while follistatin was found to bind and inactivate myostatin [184] (8), further inhibiting its proinflammatory effects.”
Follistatin, by inhibiting myostatin, might contribute to continued lipolysis in WAT.
“Follistatin, on the other hand, by inhibiting myostatin [184] (5), might also contribute to continued lipolysis in WAT.”
Cites
1 retracted
Pisconti, A., Brunelli, S., Padova, M. D., Palma, C. D., Deponti, D., Baesso, S., Sartorelli, V., Cossu, G., & Clementi, E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200507083 · Cited by 106 · see citing works
RetractedRegulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013 · see citing works
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · see citing works
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014 · see citing works
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
Langley, B. C., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204291200 · Cited by 910 · see citing works
Functional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831 · see citing works
Myostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784 · see citing works
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1999) · Nature Genetics · doi:10.1038/10320 · Cited by 471 · see citing works
The transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464 · see citing works
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & González-Cadavid, N. F. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410 · see citing works
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice
Wagner, K. R., McPherron, A. C., Winik, N., & Lee, S. (2002) · Annals of Neurology · doi:10.1002/ana.10385 · Cited by 378 · see citing works
Carlson, C. J., Booth, F. W., & Gordon, S. E. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.2.r601 · Cited by 358 · see citing works
Minetti, G., Colussi, C., Adami, R., Serra, C., Mozzetta, C., Parente, V., Fortuni, S., Straino, S., Sampaolesi, M., Padova, M. D., et al. (2006) · Nature Medicine · doi:10.1038/nm1479 · Cited by 341 · see citing works
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin
Reisz‐Porszasz, S., Bhasin, S., Artaza, J. N., Shen, R., Sinha‐Hikim, I., Hogue, A., Fielder, T. J., & González-Cadavid, N. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2003 · Cited by 333 · see citing works
Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways
Lee, S.-J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000789 · Cited by 316 · see citing works
Contribution of satellite cells to IGF‐I induced hypertrophy of skeletal muscle
Barton‐Davis, Shoturma, & Sweeney (1999) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1999.00618.x · Cited by 283 · see citing works
Amirouche, A., Durieux, A., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., Bigard, X. A., Peinnequin, A., & Freyssenet, D. G. (2008) · Endocrinology · doi:10.1210/en.2008-0959 · Cited by 282 · see citing works
Haidet, A. M., Rizo, L., Handy, C. R., Umapathi, P., Eagle, A., Shilling, C., Boué, D. R., Martin, P. T., Sahenk, Z., Mendell, J. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709144105 · Cited by 267 · see citing works
Nakashima, M., Toyono, T., Akamine, A., & Joyner, A. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00205-6 · Cited by 240 · see citing works
Sidis, Y., Mukherjee, A., Keutmann, H., Delbaere, A., Sadatsuki, M., & Schneyer, A. (2006) · Endocrinology · doi:10.1210/en.2006-0089 · Cited by 211 · see citing works
Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterningPreprint
Oh, S. P., Yeo, C., Lee, Y. J., Schrewe, H., Whitman, M., & Li, E. (2002) · Genes & Development · doi:10.1101/gad.1021802 · Cited by 196 · see citing works
Nakatani, M., Takehara, Y., Sugino, H., Matsumoto, M., Hashimoto, O., Hasegawa, Y., Murakami, T., Uezumi, A., Takeda, S., Noji, S., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8673com · Cited by 187 · see citing works
Self-citationModulating skeletal muscle mass by postnatal, muscle‐specific inactivation of the myostatin gene
Grobet, L., Pirottin, D., Farnir, F., Poncelet, D. A., Royo, L. J., Brouwers, B., Christians, E., Desmecht, D. J.-M., Coignoul, F. L., Kahn, R., et al. (2003) · genesis · doi:10.1002/gene.10188 · Cited by 182 · see citing works
Redundancy of myostatin and growth/differentiation factor 11 function
McPherron, A. C., Huynh, T. V., & Lee, S.-J. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-24 · Cited by 164 · see citing works
Durieux, A., Amirouche, A., Banzet, S., Koulmann, N., Bonnefoy, R., Pasdeloup, M., Mouret, C., Bigard, X. A., Peinnequin, A., & Freyssenet, D. G. (2007) · Endocrinology · doi:10.1210/en.2006-1500 · Cited by 162 · see citing works
Human Follistatin-Related Protein: A Structural Homologue of Follistatin with Nuclear Localization
Tortoriello, D. V., Sidis, Y., Holtzman, D. A., Holmes, W. E., & Schneyer, A. L. (2001) · Endocrinology · doi:10.1210/endo.142.8.8319 · Cited by 152 · see citing works
Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection
Dehoux, M., Beneden, R. V., Fernández-Celemı́n, L., Lause, P., & Thissen, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00505-2 · Cited by 146 · see citing works
Self-citationCharacterization of unique binding kinetics of follistatin and activin or inhibin in serum
Schneyer, A. L., Rzucidlo, D. A., Sluss, P. M., & Crowley, W. F. (1994) · Endocrinology · doi:10.1210/endo.135.2.8033815 · Cited by 143 · see citing works
Souza, T. A., Chen, X., Guo, Y., Sava, P., Zhang, J., Hill, J. J., Yaworsky, P. J., & Qiu, Y. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0290 · Cited by 142 · see citing works
Prolonged absence of myostatin reduces sarcopenia
Siriett, V., Platt, L., Salerno, M. S., Ling, N., Kambadur, R., & Sharma, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20778 · Cited by 139 · see citing works
Singh, R., Bhasin, S., Braga, M., Artaza, J. N., Pervin, S., Taylor, W. E., Krishnan, V., Sinha, S. K., Rajavashisth, T. B., & Jasuja, R. (2008) · Endocrinology · doi:10.1210/en.2008-0858 · Cited by 131 · see citing works
Bloquel, C., Fabre, E. E., Bureau, M. F., & Scherman, D. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.508 · Cited by 129 · see citing works
Welle, S. L., Burgess, K., & Mehta, S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90862.2008 · Cited by 117 · see citing works
Myofibrillar protein synthesis in myostatin-deficient mice.
Welle, S., Bhatt, K., & Pinkert, C. (2006) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2005 · Cited by 104 · see citing works
Schakman, O., Gilson, H., de Coninck, V., Lause, P., Verniers, J., Havaux, X., Ketelslegers, J., & Thissen, J. (2005) · Endocrinology · doi:10.1210/en.2004-1594 · Cited by 95 · see citing works
Self-citationGdf11 Is a Negative Regulator of Chondrogenesis and Myogenesis in the Developing Chick Limb
Gamer, L. W., Cox, K. A., Small, C. G., & Rosen, V. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9981 · Cited by 92 · see citing works
Molecular analysis of fiber type-specific expression of murine myostatin promoter
Salerno, M. S., Thomas, M., Forbes, D., Watson, T. J., Kambadur, R., & Sharma, M. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00492.2003 · Cited by 78 · see citing works
Schakman, O., Kalista, S., Bertrand, L., Lause, P., Verniers, J., Ketelslegers, J. M., & Thissen, J. (2008) · Endocrinology · doi:10.1210/en.2008-0439 · Cited by 78 · see citing works
Self-citationHypotension inNKCC1null mice: role of the kidneys
Wall, S. M., Knepper, M. A., Hassell, K. A., Fischer, M. P., Shodeinde, A., Shin, W., Pham, T. D., Meyer, J. W., Lorenz, J. N., Beierwaltes, W. H., et al. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00309.2005 · Cited by 70 · see citing works
Follistatin and its role as an activin-binding protein.
Sugino, H., Sugino, K., Hashimoto, O., Shoji, H., & Nakamura, T. (1997) · PubMed · Cited by 61 · see citing works
Opposing Effects of Activin A and Follistatin on Developing Skeletal Muscle Cells
Link, B. A., & Nishi, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3575 · Cited by 57 · see citing works
Localization of the heparin binding site of follistatin
Inouye, S., LING, N. C., & Shimasaki, S. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90094-m · Cited by 52 · see citing works
Walsh, S., Metter, E. J., Ferrucci, L., & Roth, S. M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01322.2006 · Cited by 52 · see citing works
Crystal Structures of the Heparan Sulfate-binding Domain of Follistatin
Innis, C. A., & Hyvönen, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211284200 · Cited by 48 · see citing works
Suryawan, A., Frank, J. W., Nguyen, H. V., & Davis, T. A. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000196718.47935.6e · Cited by 42 · see citing works
Changes in striated muscle following single intense doses of x-rays.
Rb, L. (2003) · PubMed · Cited by 35 · see citing works
Activin A inhibits formation of skeletal muscle during chick development
He, L., Vichev, K., Macharia, R., Huang, R., Christ, B., Patel, K., & Amthor, H. (2005) · Anatomy and Embryology · doi:10.1007/s00429-005-0454-1 · Cited by 26 · see citing works
Myostatin preferentially down-regulates the expression of fast 2x myosin heavy chain in cattle
Hayashi, S., MIYAKE, M., Watanabe, K., Aso, H., HAYASHI, S., Ohwada, S., & Yamaguchi, T. (2008) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.84.354 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089 · see citing works
Molecular and cellular mechanisms of skeletal muscle atrophy: an update
Fanzani, A., Conraads, V. M., Penna, F., & Martinet, W. (2012) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-012-0074-6 · Cited by 372 · see citing works
Skeletal muscle fibrosis: an overview
Mahdy, M. A. A. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2955-2 · Cited by 365 · see citing works
Zanou, N., & Gailly, P. L. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1330-4 · Cited by 361 · see citing works
Uraemic sarcopenia: aetiology and implications
Fahal, I. H. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft070 · Cited by 358 · see citing works
Cancer cachexia: molecular mechanisms and treatment strategies
Setiawan, T., Sari, I. N., Wijaya, Y., Julianto, N. M., Muhammad, J. A., Lee, H.-Y., Ji, H.-O.-C., & Kwon, H. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01454-0 · Cited by 300 · see citing works
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278 · see citing works
Regulation of Muscle Mass by Follistatin and Activins
Lee, S.-J., Lee, Y.-S., Zimmers, T. A., Soleimani, A., Matzuk, M. M., Tsuchida, K., Cohn, R. D., & Barton, E. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0127 · Cited by 273 · see citing works
Self-citationTGF-β Family Signaling in Mesenchymal DifferentiationPreprint
Grafe, I., Alexander, S., Peterson, J. R., Snider, T. N., Lévi, B., Lee, B., & Mishina, Y. M. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022202 · Cited by 272 · see citing works
Myogenic regulatory factors: The orchestrators of myogenesis after 30 years of discovery
Asfour, H. A., Allouh, M. Z., & Said, R. S. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217749494 · Cited by 257 · see citing works
A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
Mendell, J. R., Sahenk, Z., Malik, V., Gomez, A. M., Flanigan, K. M., Lowes, L. P., Alfano, L. N., Berry, K., Meadows, E., Lewis, S., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.200 · Cited by 246 · see citing works
Biomarkers in sarcopenia: A multifactorial approach
Curcio, F., Ferro, G., Basile, C., Liguori, I., Parrella, P., Pirozzi, F., Della‐Morte, D., Gargiulo, G., Testa, G., Tocchetti, C. G., et al. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.09.007 · Cited by 225 · see citing works
Role of Activin A and Myostatin in Human Cancer Cachexia
Loumaye, A., de Barsy, M., Nachit, M., Lause, P., Frateur, L., Maanen, A. G. V., Tréfois, P., Gruson, D., & Thissen, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4318 · Cited by 212 · see citing works
Self-citationRen, H., Gong, D., Jia, F., Xu, B., & Liu, Z. (2016) · Renal Failure · doi:10.3109/0886022x.2015.1132173 · Cited by 203 · see citing works
Hansen, J., Brandt, C., Nielsen, A. R., Hojman, P., Whitham, M., Febbraio, M. A., Pedersen, B. K., & Plomgaard, P. (2011) · Endocrinology · doi:10.1210/en.2010-0868 · Cited by 200 · see citing works
Dubois, V., Laurent, M., Boonen, S., Vanderschueren, D., & Claessens, F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0883-3 · Cited by 197 · see citing works
Brooks, N. E., & Myburgh, K. H. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00099 · Cited by 194 · see citing works
Sarcopenia – The search for emerging biomarkers
Kalinkovich, A., & Livshits, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.05.001 · Cited by 187 · see citing works
Activin A more prominently regulates muscle mass in primates than does GDF8
Latres, E., Mastaitis, J., Fury, W., Miloscio, L., Trejos, J., Pangilinan, J., Okamoto, H., Cavino, K., Na, E., Papatheodorou, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15153 · Cited by 185 · see citing works
Lee, S., Huynh, T. V., Lee, Y., Sebald, S. M., Wilcox‐Adelman, S. A., Iwamori, N., Lepper, C., Matzuk, M. M., & Fan, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206410109 · Cited by 167 · see citing works
Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps
Bączek, J., Silkiewicz, M., & Wojszel, Z. B. (2020) · Nutrients · doi:10.3390/nu12082401 · Cited by 159 · see citing works
A human embryonic limb cell atlas resolved in space and time
Zhang, B., He, P., Lawrence, J. E. G., Wang, S., Tuck, E., Williams, B. A., Roberts, K., Kleshchevnikov, V., Mamanova, L., Bolt, L., et al. (2024) · Nature · doi:10.1038/s41586-023-06806-x · Cited by 143 · see citing works
Latres, E., Pangilinan, J., Miloscio, L., Bauerlein, R., Na, E., Potocky, T. B., Huang, Y., Eckersdorff, M., Rafique, A., Mastaitis, J., et al. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0060-8 · Cited by 143 · see citing works
Myokines and Resistance Training: A Narrative Review
Zunner, B. E. M., Wachsmuth, N. B., Eckstein, M. L., Scherl, L., Schierbauer, J., Haupt, S., Stumpf, C., Reusch, L., & Moser, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073501 · Cited by 139 · see citing works
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity.
Park, M., & Choi, K. M. (2023) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2023.155577 · Cited by 106 · see citing works
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting
Breitbart, A., Auger‐Messier, M., Molkentin, J. D., & Heineke, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2011 · Cited by 131 · see citing works
Muscle wasting in heart failure: An overview
von Haehling, S., Steinbeck, L., Doehner, W., Springer, J., & Anker, S. D. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.025 · Cited by 128 · see citing works
Zhu, J., Li, Y., Lu, A., Gharaibeh, B., Ma, J., Kobayashi, T., Quintero, A., & Huard, J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.008 · Cited by 124 · see citing works
Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation
Wang, Q., & McPherron, A. C. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.226001 · Cited by 122 · see citing works
Fusion and beyond: Satellite cell contributions to loading-induced skeletal muscle adaptation
Murach, K. A., Fry, C. S., Dupont‐Versteegden, E. E., McCarthy, J. J., & Peterson, C. A. (2021) · The FASEB Journal · doi:10.1096/fj.202101096r · Cited by 120 · see citing works
Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions
Watanabe, H., Enoki, Y., & Maruyama, T. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00513 · Cited by 118 · see citing works
Characterization and Regulation of Mechanical Loading‐Induced Compensatory Muscle Hypertrophy
Adams, G. R., & Bamman, M. M. (2012) · Comprehensive physiology · doi:10.1002/cphy.c110066 · Cited by 114 · see citing works
Biomarkers of cancer cachexia.
Loumaye, A., & Thissen, J. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.07.011 · Cited by 102 · see citing works
Self-citationFollistatin Promotes Adipocyte Differentiation, Browning, and Energy Metabolism
Braga, M., Reddy, S. T., Vergnes, L., Pervin, S., Grijalva, V., Stout, D., David, J., Li, X., Tomasian, V., Reid, C. B., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m039719 · Cited by 111 · see citing works
Yamada, M., Tatsumi, R., Yamanouchi, K., Hosoyama, T., SHIRATSUCHI, S., Satô, A., Mizunoya, W., Ikeuchi, Y., Furuse, M., & Allen, R. E. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00449.2009 · Cited by 108 · see citing works
Hansen, J. S., Pedersen, B. K., Xu, G., Lehmann, R., Weigert, C., & Plomgaard, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1681 · Cited by 106 · see citing works
Sarcopenia in Chronic Kidney Disease
de Souza, V. A., de Oliveira, D., Mansur, H. N., Fernandes, N. M. D. S., & Bastos, M. G. (2015) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20150014 · Cited by 101 · see citing works
Guo, B., Zhang, Z.-K., Liang, C., Li, J., Liu, J., Lu, A., Zhang, B.-T., & Zhang, G. (2017) · Calcified Tissue International · doi:10.1007/s00223-016-0209-4 · Cited by 96 · see citing works
Braga, M., Bhasin, S., Jasuja, R., Pervin, S., & Singh, R. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.019 · Cited by 96 · see citing works
Current and Future Pharmacologic Treatment of Sarcopenia
Rolland, Y., Onder, G., Morley, J. E., Guyonnet, S., van Kan, G. A., & Vellas, B. J. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.008 · Cited by 98 · see citing works
Sciorati, C., Clementi, E., Manfredi, A. A., & Rovere, P. Q. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1857-7 · Cited by 92 · see citing works
Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass
Lee, S. (2010) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152210793663748 · Cited by 87 · see citing works
The Role of the Skeletal Muscle Secretome in Mediating Endurance and Resistance Training Adaptations
Leuchtmann, A. B., Adak, V., Dilbaz, S., & Handschin, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.709807 · Cited by 84 · see citing works
Yan, X., Huang, Y., Jx, Z., Rogers, C. J., Zhu, M.-J., Ford, S. P., Nathanielsz, P. W., & Du, . (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.69 · Cited by 82 · see citing works
β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders
Joassard, O. R., Durieux, A., & Freyssenet, D. G. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.025 · Cited by 82 · see citing works
Role of growth differentiation factor 11 in development, physiology and disease
Zhang, Y., Wei, Y. S., Liu, D., Liu, F., Li, X. A., Pan, L., Pang, Y., & Chen, D. (2017) · Oncotarget · doi:10.18632/oncotarget.20258 · Cited by 82 · see citing works
Bagheri, R., Moghadam, B. H., Church, D. D., Tinsley, G. M., Eskandari, M., Moghadam, B. H., Motevalli, M. S., Baker, J. S., Robergs, R. A., & Wong, A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110869 · Cited by 81 · see citing works
Yates, D. T., Clarke, D. S., Macko, A. R., Anderson, M. J., Shelton, L. A., Nearing, M., Allen, R. E., Rhoads, R. P., & Limesand, S. W. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.272591 · Cited by 80 · see citing works
Sevivas, N., Teixeira, F. G., Portugal, R. V., de Araujo, L. R. R., Carriço, L. F., Ferreira, N., da Silva, M. V., Espregueira‐Mendes, J., Anjo, S. I., Manadas, B. J., et al. (2016) · The American Journal of Sports Medicine · doi:10.1177/0363546516657827 · Cited by 80 · see citing works
Circulating Activin A predicts survival in cancer patients
Loumaye, A., de Barsy, M., Nachit, M., Lause, P., Maanen, A. G. V., Tréfois, P., Gruson, D., & Thissen, J. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12209 · Cited by 79 · see citing works
Self-citationBagheri, R., Rashidlamir, A., Motevalli, M. S., Elliott, B., Mehrabani, J., & Wong, A. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04180-z · Cited by 79 · see citing works
Fife, E., Kostka, J., Kroc, Ł., Guligowska, A., Pigłowska, M., Sołtysik, B. K., Kaufman‐Szymczyk, A., Fabianowska‐Majewska, K., & Kostka, T. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0888-y · Cited by 77 · see citing works
Effects of the activin A–myostatin–follistatin system on aging bone and muscle progenitor cells
Bowser, M., Herberg, S., Arounleut, P., Shi, X., Fulzele, S., Hill, W., Isales, C. M., & Hamrick, M. W. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.11.004 · Cited by 75 · see citing works
Anastasilakis, A. D., Koulaxis, D., Kefala, N., Pοlyzos, S. A., Upadhyay, J., Pagkalidou, E., Economou, F. I., Anastasilakis, C. D., & Mantzoros, C. S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.05.002 · Cited by 75 · see citing works
Han, X., Møller, L. L. V., Groote, E. D., Bojsen-Møller, K. N., Davey, J. R., Henríquez‐Olguín, C., Li, Z., Knudsen, J. R., Jensen, T. E., Madsbad, S., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12474 · Cited by 73 · see citing works
Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy
Boursereau, R., Abou-Samra, M., Lecompte, S., Noel, L., & Brichard, S. M. (2018) · BMC Biology · doi:10.1186/s12915-018-0501-z · Cited by 72 · see citing works
Ziaaldini, M. M., Koltai, E., Csende, Z., Goto, S., Boldogh, I., Taylor, A. W., & Radak, Z. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.04.008 · Cited by 72 · see citing works
Vitamin D Signaling in Myogenesis: Potential for Treatment of Sarcopenia
Wagatsuma, A., & Sakuma, K. (2014) · BioMed Research International · doi:10.1155/2014/121254 · Cited by 71 · see citing works
Muscle cell‐derived cytokines in skeletal muscle regeneration
Waldemer, R. J., Kim, D., & Chen, J. (2022) · FEBS Journal · doi:10.1111/febs.16372 · Cited by 74 · see citing works
Morine, K., Bish, L. T., Selsby, J. T., Gazzara, J. A., Pendrak, K., Sleeper, M. M., Barton, E. R., Lee, S., & Sweeney, H. L. (2010) · Muscle & Nerve · doi:10.1002/mus.21743 · Cited by 71 · see citing works
Joassard, O. R., Amirouche, A., Gallot, Y. S., Desgeorges, M. M., Castells, J., Durieux, A., Berthon, P. M., & Freyssenet, D. G. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.07.019 · Cited by 67 · see citing works
Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model
Rodino‐Klapac, L. R., Janssen, P. M. L., Shontz, K. M., Canan, B. D., Montgomery, C. L., Griffin, D., Heller, K. N., Schmelzer, L., Handy, C. R., Clark, K. R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt342 · Cited by 67 · see citing works
Lactate Stimulates a Potential for Hypertrophy and Regeneration of Mouse Skeletal Muscle
Ohno, Y., Ando, K., Ito, T., Suda, Y., Matsui, Y., Oyama, A., Kaneko, H., Yokoyama, S., Egawa, T., & Goto, K. (2019) · Nutrients · doi:10.3390/nu11040869 · Cited by 67 · see citing works
Regulation of Muscle Growth in Early Postnatal Life in a Swine Model
Rudar, M., Fiorotto, M., & Davis, T. (2018) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020518-115130 · Cited by 50 · see citing works
Follistatin: A Novel Therapeutic for the Improvement of Muscle Regeneration
Yaden, B. C., Croy, J. E., Wang, Y., Wilson, J. M., Datta‐Mannan, A., Shetler, P. K., Milner, A., Bryant, H. U., Andrews, J., Dai, G., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211169 · Cited by 64 · see citing works
Kobayashi, T., Uehara, K., Ota, S., Tobita, K., Ambrosio, F., Cummins, J. H., Terada, S., Fu, F. H., & Huard, J. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00140.2011 · Cited by 62 · see citing works
Application of bio-orthogonal proteome labeling to cell transplantation and heterochronic parabiosis
Liu, Y., Conboy, M. J., Mehdipour, M., Liu, Y., Tran, T. P., Blotnick, A. M., Rajan, P., Santos, T. C., & Conboy, I. M. (2017) · Nature Communications · doi:10.1038/s41467-017-00698-y · Cited by 60 · see citing works
Wang, M., Yu, H. M., Kim, Y., Bidwell, C. A., & Kuang, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.040 · Cited by 60 · see citing works
Kalista, S., Schakman, O., Gilson, H., Lause, P., Demeulder, B., Bertrand, L., Pende, M., & Thissen, J. (2011) · Endocrinology · doi:10.1210/en.2011-1687 · Cited by 58 · see citing works
Self-citationHepatokines—A novel group of exercise factors
Weigert, C., Hoene, M., & Plomgaard, P. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2216-y · Cited by 57 · see citing works
Stinckens, A., Georges, M., & Buys, N. (2010) · Animal Genetics · doi:10.1111/j.1365-2052.2010.02144.x · Cited by 57 · see citing works
Role of exercise-induced hepatokines in metabolic disorders
Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54 · see citing works
Pearsall, R. S., Davies, M. V., Cannell, M., Li, J., Widrick, J. J., Mulivor, A. W., Wallner, S., Troy, M., Spaits, M. S., Liharska, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47818-w · Cited by 53 · see citing works
Adiponectin and Skeletal Muscle
Jortay, J., Senou, M., Abou-Samra, M., Noel, L., Robert, A., Many, M.-C., & Brichard, S. M. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.03.035 · Cited by 52 · see citing works
Proteomic signature of muscle atrophy in rainbow trout
Salem, M., Kenney, P. B., Rexroad, C. E., & Yao, J. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.10.014 · Cited by 52 · see citing works
MicroRNAs Regulated by Adiponectin as Novel Targets for Controlling Adipose Tissue Inflammation
Ge, Q., Gérard, J., Noël, L., Scroyen, I., & Brichard, S. M. (2012) · Endocrinology · doi:10.1210/en.2012-1623 · Cited by 51 · see citing works
Iskenderian, A., Liu, N., Deng, Q., Huang, Y. L., Shen, C., Palmieri, K. J., Crooker, R., Lundberg, D. M., Kastrapeli, N., Pescatore, B., et al. (2018) · Skeletal Muscle · doi:10.1186/s13395-018-0180-z · Cited by 51 · see citing works
Guardiola, O., Lafuste, P., Brunelli, S., Iaconis, S., Touvier, T., Mourikis, P., Bock, K. D., Lonardo, E., Andolfi, G., Bouché, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204017109 · Cited by 50 · see citing works
Myostatin levels in skeletal muscle of hibernating ground squirrels
Brooks, N. E., Myburgh, K. H., & Storey, K. B. (2011) · Journal of Experimental Biology · doi:10.1242/jeb.055764 · Cited by 48 · see citing works
Treating cancer cachexia to treat cancer
Lee, S., & Glass, D. J. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-2 · Cited by 49 · see citing works
Circulating Follistatin in Patients with Chronic Kidney Disease
Miyamoto, T., Carrero, J. J., Qureshi, A. R., Anderstam, B., Heimbürger, O., Barany, P. F., Lindholm, B., & Stenvinkel, P. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10511110 · Cited by 46 · see citing works
Local induction of adiponectin reduces lipopolysaccharide-triggered skeletal muscle damage
Jortay, J., Senou, M., Delaigle, A., Noel, L., Funahashi, T., Maeda, N., Many, M. C., & Brichard, S. M. (2010) · Endocrinology · doi:10.1210/en.2009-1462 · Cited by 44 · see citing works
Khalafi, M., Aria, B., Symonds, M. E., & Rosenkranz, S. K. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114272 · Cited by 48 · see citing works
Frost, R. A., & Lang, C. H. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.012 · Cited by 44 · see citing works
Elliott, B., Herbert, P., Sculthorpe, N. F., Grace, F., Stratton, D., & Hayes, L. D. (2017) · Physiological Reports · doi:10.14814/phy2.13343 · Cited by 43 · see citing works
Pervin, S., Reddy, S. T., & Singh, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.653179 · Cited by 42 · see citing works
Zamboni, M. M., Mazzali, G., Brunelli, A., Saatchi, T., Urbani, S., Giani, A., Rossi, A. P., Zoico, E., & Fantin, F. (2022) · Cells · doi:10.3390/cells11213361 · Cited by 42 · see citing works
Hoogaars, W. M. H., & Jaspers, R. T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_8 · Cited by 42 · see citing works
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA
Schumann, C., Nguyen, D. X., Norgard, M. A., Bortnyak, Y., Korzun, T., Chan, S., Lorenz, A. S., Moses, A. S., Albarqi, H. A., Wong, L., et al. (2018) · Theranostics · doi:10.7150/thno.27847 · Cited by 42 · see citing works
Liu, M., Hammers, D. W., Barton, E. R., & Sweeney, H. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166803 · Cited by 41 · see citing works
Suzuki, M., Muro, S., Fukui, M., ISHIZAKI, N., Satô, S., Shiota, T., Endo, K., Suzuki, T., MITSUMA, T., Mishima, M., et al. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2341-3 · Cited by 40 · see citing works
Torregrosa, C., Chorin, F., Beltran, E. E. M., Neuzillet, C., & Cardot‐Ruffino, V. (2022) · Cancers · doi:10.3390/cancers14215402 · Cited by 42 · see citing works
Shi, S., Hoogaars, W. M. H., de Gorter, D. J. J., van Heiningen, S. H., Lin, H. Y.-F., Hong, C. C., Kemaladewi, D. U., Aartsma-Rus, A. M., ten Dijke, P., & Hoen, P. A. C. ’. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.003 · Cited by 39 · see citing works
Role of IGF-I in follistatin-induced skeletal muscle hypertrophy
Barbé, C., Kalista, S., Loumaye, A., Ritvos, O., Lause, P., Ferracin, B., & Thissen, J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00098.2015 · Cited by 38 · see citing works
Self-citationYaden, B. C., Wang, Y. X., Wilson, J. M., Culver, A. E., Milner, A., Datta‐Mannan, A., Shetler, P. K., Croy, J. E., Dai, G., & Krishnan, V. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.12.029 · Cited by 38 · see citing works
Lawlor, M. W., Viola, M. G., Meng, H., Edelstein, R. V., Liu, F., Yan, K., Luna, E. J., Lerch-Gaggl, A., Hoffmann, R. G., Pierson, C. R., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.03.003 · Cited by 37 · see citing works
Overcoming Insulin Insufficiency by Forced Follistatin Expression in β -cells of db/db Mice
Zhao, C., Qiao, C., Tang, R., Jiang, J., Li, J., Martin, C. B., Bulaklak, K., Li, J., Wang, D. W., & Xiao, X. (2015) · Molecular Therapy · doi:10.1038/mt.2015.29 · Cited by 37 · see citing works
A Multifactorial Approach for Sarcopenia Assessment: A Literature Review
Supriya, R., Singh, K. P., Gao, Y., Li, F., Dutheil, F., & Baker, J. S. (2021) · Biology · doi:10.3390/biology10121354 · Cited by 36 · see citing works
Nakatani, M., Kokubo, M., Ohsawa, Y., Sunada, Y., & Tsuchida, K. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2010 · Cited by 34 · see citing works
Self-citationGe, Q., Rycken, L., Noël, L., Maury, E., & Brichard, S. M. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00153.2011 · Cited by 34 · see citing works
- Authors
- Gilson, H., Schakman, O., Kalista, S., Lause, P., Tsuchida, K., & Thissen, J.-P.
- Affiliations
- UCLouvain (BE)
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2009-07
- Volume
- 297
- Issue
- 1
- Pages
- E157-E164
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2169876318
- Cited by
- 248
- References
- 48
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 6 · 2023: 13 · 2022: 11 · 2021: 14 · 2020: 16 · 2019: 13 · 2018: 19 · 2017: 17 · 2016: 13 · 2015: 17 · 2014: 22 · 2013: 17 · 2012: 17
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Funders
- Fonds Spéciaux de Recherche
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Meat and Animal Product Quality
- Keywords
- follistatin, muscle hypertrophy, satellite cells, satellite cell proliferation, myostatin, activin, TGF-beta superfamily, muscle atrophy, muscle mass regulation
- MeSH terms
- Animals, Hypertrophy, Male, Muscular Atrophy, Up-Regulation, Rats, Wistar, Mice, Knockout, Activins, Satellite Cells, Skeletal Muscle, Follistatin, Cell Proliferation, Mice, Rats, Myostatin, Rats, Transgenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review